Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Share:
Related NEOG
25 Stocks Which Rallied Four Days, Then Sold Off Yesterday
Neogen Announces Richard Crowder's Resignation As Director
Related ABAX
Canaccord Fireside Chat Takeaways For Abaxis, Heska
12 Biggest Mid-Day Losers For Friday

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.

Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio is 2.06.

Abaxis (NASDAQ: ABAX) may earn $1.11 per share in the next year ending March, 2014. Abaxis' trailing-twelve-month operating margin is 12.95%.

Trinity Biotech plc (NASDAQ: TRIB) is projected to earn $0.92 per share for the next year ending December, 2013. Trinity Biotech's trailing-twelve-month revenue is $80.67 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.88 per share over the next year ending September, 2013. Meridian Bioscience's trailing-twelve-month ROE is 22.58%.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

View Comments and Join the Discussion!